2020 Pediatric Psychopharmacology Update Institute Notebook
AACAP's 2020 Pediatric Psychopharmacology Update Institute highlights the shifting emphasis to neuroscience-based medication nomenclature and understanding the pharmacology of psychotropic medications that provide the basis for contemporary approaches to medication management across the range of clinical conditions commonly treated by child and adolescent psychiatrists. Nine top child and adolescent psychiatric research clinicians describe updated frameworks for categorizing psychiatric medications, understanding where and how these medications work in psychiatric treatments, how to make practical use of this understanding in clinical patient care, and how advances in neuromodulation and pharmacogenetics might potentially expand the clinical armamentarium.